Altered calcium homeostasis in ALS as a target for therapy

Amyotrophic Lateral Sclerosis

Volumn 1, Issue 4, 2000, Pages 27-32

  Appel, Stanley H ^a   Beers, David ^b   Smith, R Glenn ^b   Wilson, Joan E ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; CALCIUM CHANNEL STIMULATING AGENT;

AMYOTROPHIC LATERAL SCLEROSIS; DRUG EFFECT; HOMEOSTASIS; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW;

AMYOTROPHIC LATERAL SCLEROSIS; CALCITRIOL; CALCIUM; CALCIUM CHANNEL AGONISTS; HOMEOSTASIS; HUMANS;

EID: 0346041955     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/14660820052415754-1     Document Type: Article

References (76)

1. Engelhardt, JI, Siklos L, Appel SH. Altered calcium homeostasis and ultrastructure in motoneurons of mice caused by passively transferred anti-motoneuronal IgG. J Neuropath. Exp Neurol 1997; 56: 21-39. (Pubitemid 127470324)
2. Siklos L, Engelhardt JI, Alexianu ME, Gurney ME, Siddique T, Appel SH. Intracellular calcium parallels motoneuron degeneration in SOD-1 mutant mice. J Neuropathol Exp Neurol 1998 June; 57: 571-587. (Pubitemid 28265600)
3. Rothstein JD, Tsai G, Kuncl RW, et al. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol 1990; 28: 18-25. (Pubitemid 20222147)
4. Rothstein JD, Martin LJ, Kuncl RW. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 1992; 326: 1464-1468.
5. Lin CL, Bristol LA, Jin L, et al. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 1998; 20: 589-602. (Pubitemid 28153087)
6. Bowling AC, Schulz JB, Brown RH Jr, Beal MF. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 1993; 61: 2322-2325. (Pubitemid 23354097)
7. Yim MB, Kang J-H, Kwak H-S, Chock PB, Stadtman ER. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu, Zn superoxide dismutase mutant: an enhancement of free radical formation due to a decreased in Km for hydrogen peroxide. Proc Natl Acad Sci USA 1996; 93: 5709-5714. (Pubitemid 26190744)
8. +: implications for neurodegeneration. J Neurochem 1994; 63: 584-591.
9. Coyle JT, Putterfarcken P. Oxidative stress, glutamate and neurodegenerative disorders. Science 1993; 262: 689-696.
10. Tymianski M, Charlton MP, Carlen PL, Tator CH. Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons. J Neurosci 1993; 13: 2085-2104. (Pubitemid 23113418)
11. Dugan LL, Sensi S, Canzoniero LMT, et al. Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J Neurosci 1995; 15: 6377-6388.
12. + rises and consequent oxygen radical production. J Neurosci 1998; 18: 7727-7738. (Pubitemid 28441014)
13. Sheen VL, Dreyer EB, Macklis JD. Calcium-mediated neuronal degeneration following singlet oxygen production. Neuroreport 1992; 3: 705-708.
14. Kakkar P, Mehrota S, Viaswanathan PN. Interrelation of active oxygen species, membrane damage and altered calcium functions. Mol Cell Biochem 1992; 111: 11-15.
15. Rothstein JD, Jin L, Dykes-Hoberg M, Kuncl RW. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci USA 1993; 90: 6591-6595. (Pubitemid 23207259)
16. Rothstein JD, Van Kammen M, Levy AI, Martin LJ, Kuncl RW. Selective loss of glial glutamate transporter (GLT-1) in amyotrophic lateral sclerosis. Ann Neurol 1995; 38: 73-84.
17. Rothstein JD, Dykes-Hoberg M, Pardo CA, et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996; 16: 675-686. (Pubitemid 26103145)
18. Nagai M, Abe K, Okamoto K, Itoyama Y. Identiication of alternative splicing forms of GLT-1 mRNA in the spinal cord of amyotrophic lateral sclerosis patients. Neurosci Lett 1998; 244: 165-168. (Pubitemid 28226317)
19. Pedersen WA, Fu W, Keller JN, et al. Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann Neurol 1998; 44: 819-824. (Pubitemid 28516055)
20. Blanc EM, Keller JN, Fernandez S, Mattson MP. 4-hydroxy-nonenal, a lipid peroxidation product, impairs glutamate transport in cortical astrocytes. Glia 1998; 22: 149-160. (Pubitemid 28084387)
21. Carriedo SG, Yin HZ, Weiss JH. Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J Neurosci 1996; 16: 4069-4079. (Pubitemid 26192403)
22. Shaw PJ, Williams TL, Slade JY, Eggett CJ, Ince PG. Low expression of GluR2 AMPA receptor subunit protein by human motor neurons. Neuroreport 1999; 10: 261-265. (Pubitemid 29104797)
23. Takuma H, Kwak S, Yoshizawa T, Kanazawa I. Reduction of GluR2 RNA editing, a molecular change that increases calcium influx through AMPA receptors, selective in the spinal ventral gray of patients with amyotrophic lateral sclerosis. Ann Neurol 1999; 46: 806-815.
24. Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 1996; 347: 1425-1431. (Pubitemid 26161204)
25. Gurney ME, Cutting FB, Zhai P, et al. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 1996; 39: 147-157. (Pubitemid 26071564)
26. Cleveland DW. From Charcot to SOD1: mechanisms of selective motor neuron death in ALS. Neuron 1999; 24: 515-520.
27. Borchelt DR, Lee MK, Slunt HS, et al. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses signiicant activity. Proc Natl Acad Sci USA 1994; 91: 8292-8296. (Pubitemid 24253933)
28. Reaume AG, Elliott JL, Hoffman EK, et al. Motor neurons in Cu/Zn superoxide dismutase - different mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 1996; 13: 43-47. (Pubitemid 26139292)
29. Ferrante RJ, Browne SE, Shinobu LA, et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 1997; 69: 2064-2074. (Pubitemid 27452754)
30. Shaw PJ, Ince PG, Falkous G, Mantle D. Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann Neurol 1995; 38: 691-695
31. Smith R G, Henry KY, Mattson MP, Appel SH. Presence of 4-hydroxynonenal in the cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis. Ann Neurol 1998; 44: 696-699. (Pubitemid 28477861)
32. Keller JN, Mattson MP. Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system. Rev Neurosci 1998; 9: 105-116. (Pubitemid 28386642)
33. Beal MF, Ferrante RJ, Browne SE, Matthews RT, Kowall NW, Brown RH Jr. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann Neurol 1997; 42: 644-654. (Pubitemid 27439028)
34. Aguirre T, Van Den Bosch L, et al. Increased sensitivity of ibroblasts from amyotrophic lateral sclerosis patients to oxidative stress. Ann Neurol 1998; 43: 452-457. (Pubitemid 28231719)
35. Mithal NP, Radunovic A, Figlewicz DA, McMillan TJ, Leigh PN. Cells from individuals with SOD-1 associated familial amyotrophic lateral sclerosis do not have an increased susceptibility to radiation-induced free radical production or DNA damage. J Neurol Sci 1999; 164: 89-92. (Pubitemid 29256080)
36. Przedborski S, Donaldson D, Jakowec M, Kish SJ, Guttman M, Rosoklija G, Hays AP. Brain superoxide dismutase, cata-lase, and glutathione peroxidase activities in amyotrophic lateral sclerosis. Ann Neurol 1996; 39: 158-165.
37. Ince PG, Shaw PJ, Candy JM, et al. Iron, selenium and glu-tathione peroxidase activity are elevated in sporadic motor neuron disease. Neurosci Lett 1994; 182: 87-90. (Pubitemid 24362029)
38. Fujita K, Yamauchi M, Shibayama K, Ando M, Honda M, Nagata Y. Decreased cytochrome c oxidase activity but unchanged superoxide dismutase and glutathione peroxi-dase activities in the spinal cords of patients with amy-otrophic lateral sclerosis. J Neurosci Res 1996; 45: 276-281. (Pubitemid 26322816)
39. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988; 8: 623-634.
40. Lipton SA, Choi YB, Pan ZH, et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993; 364: 626-632. (Pubitemid 23274719)
41. + in toxic cell killing. Trends Pharmacol Sci 1989; 10: 281-285.
42. +)-binding proteins in human neurodegenerative disorders. Trends Neurosci 1992; 15: 259-264.
43. Colom LV, Alexianu ME, Mosier DR, Smith RG, Appel SH. Amyotrophic lateral sclerosis immunoglobulins increase intracellular calcium in a motoneuron cell line. Exp Neurol 1997; 146: 354-360. (Pubitemid 27381840)
44. 2+ currents in a motoneuron cell line. Ann Neurol 1995; 37: 102-109.
45. Engelhardt JI, Siklos L, Komuves L, Smith RG, Appel SH. Antibodies to calcium channels from ALS patients passively transferred to mice selectively increase intracellular calcium and induce ultrastructural changes in motoneurons. Synapse 1995; 20: 185-199.
46. Siklos L, Engelhardt JI, Adalbert R., Appel SH. Calcium-containing endosomes at oculomotor terminals in animal models of ALS. NeuroReport 1999; 10: 2539-2545. (Pubitemid 29418133)
47. Bolanos JP, Almeida A, Stewart V et al. Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J Neurochem 1997; 68: 2227-2240. (Pubitemid 27218141)
48. Sasaki S, Maruyama S, Yamane K, Sakuma H, Takeishi M. Ultrastructure of swollen proximal axons of anterior horn neurons in motor neuron disease. J Neurol Sci 1990; 97: 233-240. (Pubitemid 20231242)
49. Wiedemann FR, Winkler K, Kuznetsov AV, et al. Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J Neurol Sci 1998; 156: 65-72. (Pubitemid 28141041)
50. Nakano Y, Hirayama K, Terao K. Hepatic ultrastructural changes and liver dysfunction in amyotrophic lateral sclerosis. Arch Neurol 1987; 44: 103-106. (Pubitemid 17087619)
51. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, Sisodia SS, Cleveland DW, Price DL. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995; 14: 1105-1116.
52. Dal Canto MC, Gurney ME. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am J Pathol 1994; 145: 1271-1279. (Pubitemid 24378480)
53. 2+ concentration in transfected neuroblastoma SH-SY5Y cells. FEBS Lett 1997; 414: 365-368. (Pubitemid 27389396)
54. Swerdlow RH, Parks JK, Cassarino DS, et al. Mitochondria in sporadic amyotrophic lateral sclerosis. Exp Neurol 1998; 153: 135-142. (Pubitemid 28452305)
55. Borthwick GH, Johnson MA, Ince PG, Shaw PJ, Turnbull DM. Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria neuronal cell death. Ann Neurol 1999; 46: 787-790. (Pubitemid 29518143)
56. Morrison BM, Janssen WGM, Gordon JW, Morrison JH. Light and electron microscopic distribution of the AMPA receptor subunit, Glu R2, in the spinal cord of control and G68R mutant superoxide dismutase transgenic mice. J Comp Neurol 1998; 395: 523-534. (Pubitemid 28226096)
57. Celio MR, Baier W, Scharer L, de Viragh PA, Gerday C. Monoclonal antibodies directed against the calcium-binding protein parvalbumin. Cell Calcium 1988; 9: 81-86.
58. 28K. Cell Calcium 1990; 11: 599-602.
59. Alexianu ME, Ho B-K, Mohamed AH, La Bella V, Smith RG, Appel SH. The role of calcium-binding proteins in selective motor neuron vulnerability in amyotrophic lateral sclerosis. Ann Neurol 1994; 36: 846-858. (Pubitemid 24370923)
60. 28K cDNA prevents amyotrophic lateral sclerosis IgG-mediated cytotoxicity. Proc Natl Acad Sci USA 1996; 93: 6796-6801.
61. Roy J, Minotti S, Dong L, Figlewicz DA, Durham HD. Glutamate potentiates the toxicity of mutant Cu/Zn-superoxide dismutase in motor neurons by postsynaptic calcium-dependent mechanisms. J Neurosci 1998; 18: 9673-9684. (Pubitemid 28543748)
62. 3 cell line alters calcium currents and intracellular calcium in homeostasis. Neuron 1992; 9: 943-954.
63. Appel SH. Excitotoxic neuronal cell death in amyotrophic lateral sclerosis. Trends Neurosci 1993; 16: 3-4.
64. DeViragh PA, Haglid KG, Celio MR. Parvalbumin increases in the putamen of rats with vitamin D hypervitaminosis. Proc Natl Acad Sci USA 1989; 86: 3887-3890. (Pubitemid 19141848)
65. 3-dependent up-regulation of calcium-binding proteins in motoneuron cells. J Neurosci Res 1998; 51: 58-66. (Pubitemid 28063148)
66. 3 sites of action in the brain. Histochem 1994; 87: 393-406.
67. 3 receptor in target cells. Endocrinology 1988; 122: 1224-1230. (Pubitemid 18091946)
68. 3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways. J. Steroid Biochem. Mol Biol 1992; 41: 231-240.
69. 28k) in rat olfactory bulb. Brain Res 1992; 578: 305-310.
70. Yamaguchi T, Keino K, Fukuda J. The effect of insulin-like growth factor-1 on the expression of calretinin and calbindin D-28K in rat embryonic neurons in culture. Neurochem.Int 1995; 26: 255-262.
71. 3 receptors: Gene regulation and genetic circuitry. FASEB J 1988; 2: 3043-3053. (Pubitemid 19021165)
72. 2+ exchange. Endocrinology 1989; 123: 2765-2776. (Pubitemid 19154107)
73. 3 exerts regional effects in the central nervous system during experimental allergic encephalomyellitis. J Neuropathol Exp Neurol 1996; 55: 904-914. (Pubitemid 26287007)
74. 3 regulates γ-glutamyl transpeptidase activity in rat brain. Neurosci Lett 1996; 216: 183-186. (Pubitemid 26336564)
75. Bouillon R, Okamura WH, Norman AW. Structure-function relationships in the vitamin D endocrine system. Endocr Rev 1995; 16: 200-257.
76. Hansen CM, Maenpaa PH. EB 1089, a novel vitamin D analog with strong antiproliferative and differentiation-inducing effects on target cells. Biochem Pharmacol 1997; 54: 1173-1179. (Pubitemid 27497244)